ESTRO 2025

It is my great pleasure to invite you back to Vienna, Austria for ESTRO 2025 which will take place from 2 to 6 May. Building on the huge success of previous congresses in this vibrant city, situated ideally in the centre of Europe, we will convene the radiation oncology community for five days of learning, collaborating and connecting.

The ambition of ESTRO to further reinforce radiation oncology as a key partner in multidisciplinary cancer care, and to guarantee accessible and high-value radiation therapy for all cancer patients who need it, is expressed in the society’s vision statement for 2030: ‘Radiation Oncology. Optimal Health for All, Together.’

Continuous evolution and refinement of radiation oncology is one important path of innovation to achieve this goal. ESTRO 2025 will put an emphasis on breakthrough research and innovation. Such revolutionary innovation is happening within our discipline, and even more opportunities open by collaboration and partnership with neighbouring and even distant fields of research. With this aim, the congress theme is Transformative Innovation Through Partnership. The programme will focus on how all stakeholders can learn from each other and cooperate to push the boundaries of radiation oncology and multidisciplinary cancer care in general. The theme will be reflected throughout the programme via state-of-the-art sessions.

The programme will emphasise interaction between audience and faculty, making top-level science accessible for all attending. Featuring panel discussions, pitch sessions and debates, the programme will connect the whole radiotherapy community. Leaders in the field will share their work and knowledge via symposia and teaching lectures. Joint sessions with partner associations will connect delegates with new communities and increase the reach of the ESTRO population. Nurturing those starting out in their careers remains a pillar of the society and therefore the Young Track will continue to provide educational activities focussed on those in the earlier stages of their careers. All sessions will promote collaboration between faculty and audience.

ESTRO strives to showcase the top-level scientific work being carried out by the radiation oncology community. With this in mind, the best abstract submitted to each track will be celebrated in a best proffered paper session. Other sessions will showcase the latest trial results. In addition to these highlight sessions, ESTRO will recognise the top-tier abstracts submitted to the congress. The highly popular mini-oral sessions will continue, enhancing the visibility of submitted research, while poster discussion sessions offer a platform to showcase work. We will continue to emphasise the interdisciplinarity of the ESTRO scientific programme by calling for abstracts which are of interest to a broad range of disciplines.

The main purpose of the ESTRO annual congress is to disseminate the latest science within the world of radiotherapy but also to reach out to the larger medical community and society in general. We will be increasing our communication of the breakthrough science via social channels and the press both during and after the congress. This will ensure engagement for those presenting at ESTRO 2025 far beyond the congress itself.

Networking with corporate partners is always invaluable. ESTRO 2025 will host Europe’s largest industry exhibition in radiation oncology. It will offer you a unique opportunity to interact with industry leaders and to find out about the latest innovations in the field.

We look forward to welcoming you in Vienna.

With warm regards,

Matthias Guckenberger

ESTRO President
ESTRO 2025 Chair

Important Notice

There are an increasing number of fraudulent websites impersonating ESTRO 2025 and we would like to warn all participants to be aware of possible scams and strongly advise that you only use you only use official ESTRO channels for registration, event information, and bookings.

ESTRO members 2025 can benefit from a substantially reduced registration fee. To benefit from this member rate, please visit themembership page to become a member or renew your 2025 membership BEFORE proceeding with your order and discover the other membership advantages.

*ESTRO Members with specialty RTT may register at the In-training fee.

*To register as a student, you should be an ESTRO member and send a copy of your valid student card to [email protected] before completing the registration. Institute letter is not accepted.

** Participants from emerging countries may register at a preferential rate. Emerging country fee applies to individuals from low-income and lower-middle-income economies as listed by the World Bank listing. You can check the list in here.

Group Registration

To make a group booking, kindly review our Group Registration procedure. Please ensure you fill out the group booking registration form, which you can find here, and return it to [email protected].

If you have any questions, please contact us at [email protected].

IMPORTANT reminder: Each participant must register using their individual email address, as they will each receive their unique login for the ESTRO 2025 apps.

Payment

The payment for web booking is processed securely through a credit card or direct debit card (normal bank card). If you'd like to pay with bank transfer, please send all your complete requests and the invoicing address to [email protected].

Insurance

The organiser does not accept liability for individual medical, travel or personal insurance. Participants are strongly advised to take out their own personal insurance policies.

Cancellation and Refund

You may cancel your registration and get a full refund of the registration fee minus handling charges of 15%. This option is available until 1 month before the congress. Any cancellation request received within 1 month before the date of the congress will not be eligible for a refund. Please send an email with your request to [email protected].

Registration Policy

We invite you to read our ESTRO 2025 Registration policy and Sale & Service policy.